High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition

被引:12
作者
Krishna, Shagun [1 ]
Borrel, Alexandre [2 ]
Huang, Ruili [3 ]
Zhao, Jinghua [3 ]
Xia, Menghang [3 ]
Kleinstreuer, Nicole [1 ]
机构
[1] NIEHS, Div Natl Toxicol Program, Res Triangle Pk, NC 27560 USA
[2] Silent Spring Inst, Newton, MA 02460 USA
[3] Natl Ctr Adv Translat Sci NCATS, Div Preclin Innovat, Bethesda, MD 20892 USA
来源
BIOLOGY-BASEL | 2022年 / 11卷 / 02期
基金
美国国家卫生研究院;
关键词
cardiovascular; hERG; Tox21 high-throughput screening; environmental chemicals; in silico modeling; QSAR models; POTASSIUM CHANNEL BLOCKAGE; CARDIAC-ARRHYTHMIA; DRUGS; DISINFECTANTS; PROLONGATION; TERFENADINE; MECHANISM; AFFINITY; INTERVAL; BROMIDE;
D O I
10.3390/biology11020209
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary Cardiovascular disease is the leading cause of death for people of most ethnicities in the United States. The human ether-a-go-go-related gene (hERG) potassium channel plays a pivotal role in cardiac rhythm regulation, and cardiotoxicity associated with hERG inhibition by drug molecules and environmental chemicals is a major public health concern. An evaluation of the effect of environmental chemicals on hERG channel function can help inform the potential public health risks of these compounds. To assess the cardiotoxic effect of diverse drugs and environmental compounds, the Tox21 federal research program has screened a collection of 9667 chemicals for inhibitory activity against the hERG channel. A set of molecular descriptors covering physicochemical and structural properties of chemicals, self-organizing maps, and hierarchical clustering were applied to characterize the chemicals inhibiting hERG. Machine learning approaches were applied to build robust statistical models that can predict the probability of any new chemical to cause cardiotoxicity via this mechanism. Chemical inhibition of the human ether-a -go-go-related gene (hERG) potassium channel leads to a prolonged QT interval that can contribute to severe cardiotoxicity. The adverse effects of hERG inhibition are one of the principal causes of drug attrition in clinical and pre-clinical development. Preliminary studies have demonstrated that a wide range of environmental chemicals and toxicants may also inhibit the hERG channel and contribute to the pathophysiology of cardiovascular (CV) diseases. As part of the US federal Tox21 program, the National Center for Advancing Translational Science (NCATS) applied a quantitative high throughput screening (qHTS) approach to screen the Tox21 library of 10,000 compounds (~7871 unique chemicals) at 14 concentrations in triplicate to identify chemicals perturbing hERG activity in the U2OS cell line thallium flux assay platform. The qHTS cell-based thallium influx assay provided a robust and reliable dataset to evaluate the ability of thousands of drugs and environmental chemicals to inhibit hERG channel protein, and the use of chemical structure-based clustering and chemotype enrichment analysis facilitated the identification of molecular features that are likely responsible for the observed hERG activity. We employed several machine-learning approaches to develop QSAR prediction models for the assessment of hERG liabilities for drug-like and environmental chemicals. The training set was compiled by integrating hERG bioactivity data from the ChEMBL database with the Tox21 qHTS thallium flux assay data. The best results were obtained with the random forest method (~92.6% balanced accuracy). The data and scripts used to generate hERG prediction models are provided in an open-access format as key in vitro and in silico tools that can be applied in a translational toxicology pipeline for drug development and environmental chemical screening.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking
    Caporuscio, Fabiana
    Rastelli, Giulio
    Imbriano, Carol
    Del Rio, Alberto
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (12) : 4006 - 4017
  • [2] Development of a Thyroperoxidase Inhibition Assay for High-Throughput Screening
    Paul, Katie B.
    Hedge, Joan M.
    Rotroff, Daniel M.
    Hornung, Michael W.
    Crofton, Kevin M.
    Simmons, Steven O.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2014, 27 (03) : 387 - 399
  • [3] A novel structure-based virtual screening model for the hERG channel blockers
    Du, Lupei
    Li, Minyong
    You, Qidong
    Xia, Lin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 355 (04) : 889 - 894
  • [4] Predictive models for hERG channel blockers: Ligand-based and structure-based approaches
    Thai, Khac-Minh
    Ecker, Gerhard F.
    CURRENT MEDICINAL CHEMISTRY, 2007, 14 (28) : 3003 - 3026
  • [5] Quantitative High-Throughput Screening for Chemical Toxicity in a Population-Based In Vitro Model
    Lock, Eric F.
    Abdo, Nour
    Huang, Ruili
    Xia, Menghang
    Kosyk, Oksana
    O'Shea, Shannon H.
    Zhou, Yi-Hui
    Sedykh, Alexander
    Tropsha, Alexander
    Austin, Christopher P.
    Tice, Raymond R.
    Wright, Fred A.
    Rusyn, Ivan
    TOXICOLOGICAL SCIENCES, 2012, 126 (02) : 578 - 588
  • [6] Microfluidic Cell Culture and Its Application in High-Throughput Drug Screening: Cardiotoxicity Assay for hERG Channels
    Su, Xiaojing
    Young, Edmond W. K.
    Underkofler, Heather A. S.
    Kamp, Timothy J.
    January, Craig T.
    Beebe, David J.
    JOURNAL OF BIOMOLECULAR SCREENING, 2011, 16 (01) : 101 - 111
  • [7] High-Throughput Electrophysiology Screen Revealed Cardiotoxicity of Strychnine by Selectively Targeting hERG Channel
    Wang, Taiyi
    Chen, Xiaonan
    Yu, Jiahui
    Du, Qunqun
    Zhu, Jie
    Yang, Mingzhu
    Wu, Honghua
    Wang, Meng
    Zhu, Yan
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2018, 46 (08): : 1825 - 1840
  • [8] Integration of Dosimetry, Exposure, and High-Throughput Screening Data in Chemical Toxicity Assessment
    Wetmore, Barbara A.
    Wambaugh, John F.
    Ferguson, Stephen S.
    Sochaski, Mark A.
    Rotroff, Daniel M.
    Freeman, Kimberly
    Clewell, Harvey J., III
    Dix, David J.
    Andersen, Melvin E.
    Houck, Keith A.
    Allen, Brittany
    Judson, Richard S.
    Singh, Reetu
    Kavlock, Robert J.
    Richard, Ann M.
    Thomas, Russell S.
    TOXICOLOGICAL SCIENCES, 2012, 125 (01) : 157 - 174
  • [9] Development and validation of CYP26A1 inhibition assay for high-throughput screening
    Sakamuru, Srilatha
    Ma, Dongping
    Pierro, Jocylin D.
    Baker, Nancy C.
    Kleinstreuer, Nicole
    Cali, James J.
    Knudsen, Thomas B.
    Xia, Menghang
    BIOTECHNOLOGY JOURNAL, 2024, 19 (06)
  • [10] A place for high-throughput electrophysiology in cardiac safety:: Screening hERG cell lines and novel compounds with the IonWorks HT™ system
    Guthrie, H
    Livington, FS
    Gubler, U
    Garippa, R
    JOURNAL OF BIOMOLECULAR SCREENING, 2005, 10 (08) : 832 - 840